Overview

Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis

Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the addition of Low Dose Naltrexone to standard endometriosis treatments will improve patient reported endometriosis associated pain.
Phase:
Phase 3
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Treatments:
Naltrexone
Norethindrone
Norethindrone Acetate